Researchers of the University of Melbourne have recognised an anti-malarial compound (ML901) through their research. With ML901, researchers at the University of Melbourne will change disease into medicine. This medicine will treat millions of people infected with malaria all across the world. Researchers working on this project said that this compound will not harm any human or mammal cells. Leann Tilley, a professor at the University of Melbourne, said, “the ML901 compound effectively made the parasite the agent of its own demise, underpinning its potency and selectivity. It works by an unusual reaction-hijacking mechanism”.
The website uses cookies to provide the best user experience while browsing safely. You can read more about cookies in the Privacy Policy. Read More
Accept Cookies Choose CookiesThese necessary cookies are integral to the website's functionality and cannot be disabled in our systems. They respond to your actions, such as managing privacy preferences, logging in, or completing forms for requested services. Whereas you can block or receive alerts about these cookies in your browser settings, certain site features may be impacted. Additionally, they do not store any personally identifiable information.
Activate these cookies for enhanced website functionality and personalization. Without them, some or all of the provided services may not function optimally.
Enable these cookies to count visits and analyze traffic sources, enhance website performance measurement and improvement. Discover the most and least popular pages while understanding visitor navigation. Rest assured, all data collected by these cookies is aggregated and remains completely anonymous.